PMID- 26342279 OWN - NLM STAT- MEDLINE DCOM- 20160824 LR - 20181113 IS - 1559-1166 (Electronic) IS - 0895-8696 (Linking) VI - 57 IP - 4 DP - 2015 Dec TI - Propofol Attenuates Early Brain Injury After Subarachnoid Hemorrhage in Rats. PG - 538-45 LID - 10.1007/s12031-015-0634-2 [doi] AB - Our previous studies demonstrated that propofol protects rat brain against focal cerebral ischemia. However, whether propofol attenuates early brain injury after subarachnoid hemorrhage in rats remains unknown until now. The present study was performed to evaluate the effect of propofol on early brain injury after subarachnoid hemorrhage in rats and further explore the potential mechanisms. Sprague-Dawley rats underwent subarachnoid hemorrhage (SAH) by endovascular perforation then received treatment with propofol (10 or 50 mg/kg) or vehicle after 2 and 12 h of SAH. SAH grading, neurological scores, brain water content, Evans blue extravasation, the myeloperoxidase activity, and malondialdehyde (MDA) content were measured 24 h after SAH. Expression of nuclear factor erythroid-related factor 2 (Nrf2), nuclear factor-kappa B (NF-kappaB) p65, and aquaporin 4 (AQP4) expression in rat brain were detected by Western blot. Expression of cyclooxygenase-2 (COX-2) and matrix metalloproteinase-9 (MMP-9) were determined by reverse transcription-polymerase chain reaction (RT-PCR). Expressions of tumor necrosis factor-alpha (TNF-alpha) and interleukin-1beta (IL-1beta) were assessed by ELISA. Neurological scores, brain water content, Evans blue extravasation, the myeloperoxidase activity, and MDA content were significantly reduced by propofol. Furthermore, expression of Nrf2 in rat brain was upregulated by propofol, and expression of NF-kappaB p65, AQP4, COX-2, MMP-9, TNF-alpha, and IL-1beta in rat brain were attenuated by propofol. Our results demonstrated that propofol improves neurological scores, reduces brain edema, blood-brain barrier (BBB) permeability, inflammatory reaction, and lipid peroxidation in rats of SAH. Propofol exerts neuroprotection against SAH-induced early brain injury, which might be associated with the inhibition of inflammation and lipid peroxidation. FAU - Shi, Song-sheng AU - Shi SS AD - Department of Neurosurgery, The Affiliated Union Hospital of Fujian Medical University, Neurosurgery Research Institute of Fujian Province, No. 29 Xinquan Road, Fuzhou, Fujian, 350001, China. FAU - Zhang, Hua-bin AU - Zhang HB AD - Department of Neurosurgery, The Affiliated Union Hospital of Fujian Medical University, Neurosurgery Research Institute of Fujian Province, No. 29 Xinquan Road, Fuzhou, Fujian, 350001, China. FAU - Wang, Chun-hua AU - Wang CH AD - Department of Neurosurgery, The Affiliated Union Hospital of Fujian Medical University, Neurosurgery Research Institute of Fujian Province, No. 29 Xinquan Road, Fuzhou, Fujian, 350001, China. FAU - Yang, Wei-zhong AU - Yang WZ AD - Department of Neurosurgery, The Affiliated Union Hospital of Fujian Medical University, Neurosurgery Research Institute of Fujian Province, No. 29 Xinquan Road, Fuzhou, Fujian, 350001, China. FAU - Liang, Ri-sheng AU - Liang RS AD - Department of Neurosurgery, The Affiliated Union Hospital of Fujian Medical University, Neurosurgery Research Institute of Fujian Province, No. 29 Xinquan Road, Fuzhou, Fujian, 350001, China. FAU - Chen, Ye AU - Chen Y AD - Department of Neurosurgery, The Affiliated Union Hospital of Fujian Medical University, Neurosurgery Research Institute of Fujian Province, No. 29 Xinquan Road, Fuzhou, Fujian, 350001, China. FAU - Tu, Xian-kun AU - Tu XK AD - Department of Neurosurgery, The Affiliated Union Hospital of Fujian Medical University, Neurosurgery Research Institute of Fujian Province, No. 29 Xinquan Road, Fuzhou, Fujian, 350001, China. unionnstu@hotmail.com. LA - eng PT - Journal Article PT - Research Support, Non-U.S. Gov't DEP - 20150905 PL - United States TA - J Mol Neurosci JT - Journal of molecular neuroscience : MN JID - 9002991 RN - 0 (Aqp4 protein, rat) RN - 0 (Aquaporin 4) RN - 0 (Interleukin-1beta) RN - 0 (NF-E2-Related Factor 2) RN - 0 (NF-kappa B) RN - 0 (Nfe2l2 protein, rat) RN - 0 (Tumor Necrosis Factor-alpha) RN - EC 1.14.99.1 (Cyclooxygenase 2) RN - EC 3.4.24.35 (Matrix Metalloproteinase 9) RN - EC 3.4.24.35 (Mmp9 protein, rat) RN - YI7VU623SF (Propofol) SB - IM MH - Animals MH - Aquaporin 4/genetics/metabolism MH - Blood-Brain Barrier/drug effects/metabolism MH - Cyclooxygenase 2/genetics/metabolism MH - Interleukin-1beta/genetics/metabolism MH - Male MH - Matrix Metalloproteinase 9/genetics/metabolism MH - NF-E2-Related Factor 2/genetics/metabolism MH - NF-kappa B/genetics/metabolism MH - Propofol/pharmacology/*therapeutic use MH - Rats MH - Rats, Sprague-Dawley MH - Subarachnoid Hemorrhage/*drug therapy/metabolism MH - Tumor Necrosis Factor-alpha/genetics/metabolism OTO - NOTNLM OT - Cyclooxygenase-2 OT - Inflammation OT - Matrix metalloproteinase-9 OT - Nuclear factor erythroid-related factor 2 OT - Nuclear factor-kappa B OT - Propofol OT - Subarachnoid hemorrhage EDAT- 2015/09/08 06:00 MHDA- 2016/08/25 06:00 CRDT- 2015/09/07 06:00 PHST- 2015/06/10 00:00 [received] PHST- 2015/07/28 00:00 [accepted] PHST- 2015/09/07 06:00 [entrez] PHST- 2015/09/08 06:00 [pubmed] PHST- 2016/08/25 06:00 [medline] AID - 10.1007/s12031-015-0634-2 [pii] AID - 10.1007/s12031-015-0634-2 [doi] PST - ppublish SO - J Mol Neurosci. 2015 Dec;57(4):538-45. doi: 10.1007/s12031-015-0634-2. Epub 2015 Sep 5.